stockrowRoyalty Pharma PLC
RPRX Healthcare Biotechnology
Royalty Pharma PLC’s revenue for fiscal 2025 (year ended December 2025) was $2.4 billion, up 5.06% from fiscal 2024.
- Revenue
- +13.3%
- EPS
- −51.5%
- Free cash flow
- +364.6%
- Total debt
- −4.00%
Quarter to September 2026, against a year earlier
Follow RPRX
Alert me
Royalty Pharma PLC (RPRX) Operating margin
Royalty Pharma PLC's operating margin over the twelve months to 30 September 2026 was 57.1%, down 8.4 percentage points from fiscal 2025 (65.6%). Over the past ten years it has ranged from 13.7% (fiscal 2022) to 144.6% (fiscal 2019); the current reading is higher than 63% of that period. That is above the Biotechnology industry median of 0.00% and above the Healthcare sector median of 0.00%.
Operating margin, annual
Embed this chart
Annual newest first
| Period | Operating margin | Change (points) |
|---|---|---|
| FY2025 | 65.6% | 8.48 |
| FY2024 | 57.1% | (6.27) |
| FY2023 | 63.4% | 49.64 |
| FY2022 | 13.7% | (48.76) |
| FY2021 | 62.5% | (12.68) |
| FY2020 | 75.2% | (69.42) |
| FY2019 | 144.6% | 68.57 |
| FY2018 | 76.0% | — |
Quarterly newest first
| Period | Operating margin | Change (points) |
|---|---|---|
| Sep 2026 | 59.5% | 39.78 |
| Jun 2026 | 19.8% | (69.54) |
| Mar 2026 | 89.3% | 26.85 |
| Dec 2025 | 62.4% | (7.67) |
| 25 more quarters | Free account |
Against its own ten years
Operating margin against peers
| Company | Operating margin |
|---|---|
| RPRX Royalty Pharma PLC | 57.1% |
| ARGX argenex SE compare | 29.3% |
| GMAB Genmab A/S Sponsored ADR compare | 26.0% |
| ONC BeOne Medicines Ltd. - Sponsored ADR compare | 17.8% |
| INCY Incyte Corporation compare | 10.4% |
| INSM Insmed, Inc. compare | −37.1% |
| BNTX BioNTech SE Sponsored ADR compare | −79.0% |
| RVMD Revolution Medicines, Inc. compare | −805.8% |
| ROIV Roivant Sciences Ltd. compare | −7,914.8% |
| Biotechnology industry median | 0.00% |
| Healthcare sector median | 0.00% |
| Market median | 0.00% |
What Operating margin is
EBIT Margin tells an investor how much operating profit, before interest and taxes, a company keeps from each unit of revenue.
EBIT ÷ Revenue
More on RPRX
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement